RESUMO

PURPOSE: To evaluate the effectiveness of gamified versus nongamified health promotion interventions on cardiometabolic health and fitness parameters in healthcare worker women. DESIGN: Randomized parallel group trial. SETTING: A public outpatient health center in Brazil. SUBJECTS: Women employees (included: n = 29; lost to follow-up: n = 1; analyzed: n = 28). INTERVENTIONS: 8 weeks of gamified (n = 15) or nongamified (n = 13) interventions, consisting of health lectures, nutritional counseling, and supervised exercise training. The gamified group was divided into teams that received points based on completion of health goals/tasks. MEASURES: Anthropometric, cardiometabolic and physical fitness parameters. ANALYSIS: Two-way ANOVA with repeated measures (group vs. time), and Bonferroni post hoc tests. RESULTS: Body mass (-1.5 ± 1.5 kg), waist circumference (-1.6 ± 3.0 cm), HbA1C (-.2 ± .3%), triglycerides (-21.5 ± 48.2 mg/dl), systolic (-11.1 ± 7.9 mmHg) and diastolic (-7.1 ± 5.8 mmHg) blood pressure, as well as sit and reach (3.9 ± 3.0 cm) and six-minute walking (56 ± 37 m) performance improved (P < .05) only after the gamified intervention. Sit-to-stand performance improved after both the gamified (-1.18 ± 1.24 s) and nongamified (-1.49 ± 1.87 s) interventions. CONCLUSION: The gamified intervention was more effective than the nongamified intervention for improving cardiometabolic and physical fitness parameters, suggesting that gamification may be an effective tool for promoting health in healthcare worker women.

Assuntos

RESUMO

Systemic sclerosis (SSc) is an autoimmune disease characterized by systemic inflammation, endothelial dysfunction, generalized fibrosis and high cardiovascular mortality. The evaluation of cardiovascular risk through the visceral adiposity index (VAI) has been helpful due to its direct relationship to the body and visceral fat percentage. We evaluated the influence of body composition and anthropometrics on cardiovascular risk as measured by VAI in healthy controls (HC) and SSc. An analytical cross-sectional study of 66 participants (33 SSc and 33 HC), mean age 52.7 ± 10, 95% women, was conducted from August 2020 to January 2021. Inclusion criteria in cases were consecutive patients with SSc (ACR/EULAR 2013), 63.6% were diffuse cutaneous (dcSS) subtype, and 36.4 were limited cutaneous (lcSS) subtype. HC was matched by age and gender. Serum lipid profiles and InBody anthropometrics were analyzed and compared. We performed descriptive statistics, bivariate analysis with Student's t, or Mann-Whitney U, correlation and chi-square according to the variable type and distribution. Total cholesterol was significantly higher in SSc than HC (345 vs 194, p = < 0.001). The BMI was higher in HC (26.2 vs 28.9, p < 0.001). Kilograms of muscle (19.8 vs 28.9, p < 0.001) and total fat (23.4 vs 28.9, p < 0.001) were lower in SSc patients compared to HC. VAI was similar when BMI < 25, but significantly higher when BMI > 25 in SSc than in HC (3 vs 1.9, p = 0.030). The increase in BMI at overweight or obese in SSc is associated with a significant increase in cardiovascular risk.

Assuntos

RESUMO

INTRODUCCIÓN: Las prácticas de crianza en alimentación y la conducta alimentaria han sido ampliamente estudiadas en niños, sin embargo, es necesario proporcionar información sobre su impacto en adultos. La evidencia sugiere que las prácticas de crianza en alimentación pueden tener un impacto en la conducta alimentarias emocional, descontrolada, restrictiva y desordenada, las cuales están asociadas con el incremento del Índice de masa corporal (IMC), el sobrepeso y la obesidad, mismos que se encuentran como principal factor de riesgo para el desarrollo de DT2. OBJETIVO: analizar través de una revisión sistemática la evidencia existente acerca de la relación entre las prácticas de crianza en alimentación, la conducta alimentaria y el riesgo de diabetes en adultos. METODOLOGÍA: Se realizó una búsqueda de literatura publicada de 2013 a 2023 en las bases de datos Pubmed, Scopus, EBSCOhost, Clarivate Science Citation Index Expanded y SpringerLink. Se identificaron 459 estudios, luego de aplicar los criterios de exclusión, se revisaron 15 estudios en total. RESULTADOS: Las subescalas de las prácticas de crianza en alimentación más empleadas fueron: preocupación, control, presión para comer y restricción. Se encontró asociación entre las prácticas de crianza en alimentación, la conducta alimentaria y el incremento del IMC. CONCLUSIÓN: Se consideran insuficientes las investigaciones que muestran el impacto de las prácticas de crianza en alimentación sobre la conducta alimentaria y si estas a su vez tienen efectos en el riesgo de diabetes en la etapa adulta.

INTRODUCTION: Parenting practices in feeding and eating behavior have been widely studied in children, however, it is necessary to provide information on their impact on adults. The evidence suggests that parenting practices in feeding can have an impact on emotional, uncontrolled, restrictive and disordered eating behavior, which are associated with an increase in BMI, overweight and obesity, which are found as the main factor of risk for the development of T2D. OBJECTIVE: To analyze, through a systematic review, the existing evidence about the relationship between parenting feeding practices, eating behavior and the risk of diabetes in adults. METHODOLOGY: A search of literature published from 2013 to 2023 was carried out in the Pubmed, Scopus, EBSCOhost, Clarivate Science Citation Index Expanded and SpringerLink databases. 459 studies were identified, after applying the exclusion criteria, 15 studies in total were reviewed. RESULTS: The subscales of the most frequently used parenting practices in feeding were: concern, control, pressure to eat and restriction. An association was found between parenting feeding practices, eating behavior and increased BMI. CONCLUSION: Research showing the impact of parenting feeding practices on eating behavior and whether these in turn have effects on the risk of diabetes in adulthood are considered insufficient.

RESUMO

Recent evidence shows the cardiometabolic effects of estrogen administration in postmenopausal women. Women have a cardiometabolic advantage during their reproductive years, which is lost at menopause due to declining estradiol (E2). E2, also known as 17-beta-estradiol, has diverse effects in its target tissues, including the cardiovascular (CV) system, through genomic and non-genomic signaling. Metabolic changes characteristic of menopause include a worsening lipid profile, changes in body fat distribution, epicardial and pericardial fat deposition, increased susceptibility to weight gain, and increased blood pressure, resulting in an increased risk of accelerated cardiovascular disease (CVD) development. E2 mediates its cardioprotective actions by increasing mitochondrial biogenesis, angiogenesis, and vasodilation, decreasing reactive oxygen species (ROS) and oxidative stress, and modulating the renin-angiotensin-aldosterone system (RAAS). In this review, we assess whether it is prudent to develop an approach to managing postmenopausal women based on modifying the patient's CV risk that includes human-identical hormone replacement therapy (HRT), modulation of RAAS, and stimulating mitochondrial biogenesis. Further research is needed to assess the safety and benefit of HRT to reduce cardiometabolic risk.

Assuntos

RESUMO

BACKGROUND: Although there is relevant information regarding the consequences of the coronavirus SARS-CoV-2 (COVID-19), little is known about the impact of the imposed social confinement (at home) on the development of exercise training programmes in populations with morbid obesity. AIM: To describe the effects of the imposed COVID-19 confinement on the cardiometabolic health benefits acquired through a concurrent training programme that started before the pandemic in populations with morbid obesity. METHODS: This was an experimental randomized clinical study, in which sedentary morbidly obese women were assigned 1:1 to a high-intensity interval training (HIIT) plus resistance training (RT) group (HIIT + RT; n = 11; BMI 42.1 ± 6.6) or to the same exercise dose, but in different order group of RT plus HIIT group (RT + HIIT; n = 7; BMI 47.5 ± 8.4). Both groups undertook two sessions/week. When COVID-19 confinement at home started, a post-test was applied in January 2020 (Post1) and after 20 months (Post2). The main outcomes were waist circumference (WC), systolic (SBP) and diastolic blood pressure (DBP), high-density lipids (HDL-c), triglycerides (Tg), and fasting plasma glucose (FPG). RESULTS: In the HIIT + RT group, the WC showed significant increases from Post1 to Post2 (Δ + 3.1 cm, p = 0.035); in the RT + HIIT group, it decreased from Post1 to Post2 (Δ - 4.8 cm, p = 0.028). In the HIIT + RT group, SBP showed significant increases from Post1 to Post2 (Δ + 6.2 mmHg, p = 0.041); the RT + HIIT group decreased SBP from Pre0 to Post1 (Δ - 7.2 mmHg, p = 0.026) and increased DBP from Pre0 to Post1 (Δ + 8.1 mmHg, p = 0.015). Tg in the HIIT + RT group decreased from Pre0 to Post1 (Δ - 40.1 mg/dL, p = 0.023) but increased from Post1 to Post2 (Δ + 86.3 mg/dL, p < 0.0001). CONCLUSIONS: The COVID-19 social confinement worsened metabolic syndrome (MetS) outcomes that had improved from 20 weeks' RT + HIIT during the training period, such as WC, SBP, and Tg from HIIT + RT, when, worryingly, SBP increased to another more serious clinical classification in both groups.

Assuntos

RESUMO

Objetivo: Determinar los niveles séricos de sCD36, molécula relacionada al metabolismo lipídico, en poblaciones de la altura y del nivel del mar, y establecer la asociación de este parámetro con factores de riesgo cardiometabólico. Materiales y métodos: Participaron 45 personas de Carhuamayo (4100 msnm) y 40 personas de Mala (30 msnm). Se midió el peso, talla y presión arterial. Se determinó la hemoglobina en sangre total, y la glucosa, perfil lipídico y sCD36 en suero. Resultados: Se encontró en la población de Carhuamayo niveles de hemoglobina significativamente mayores, mientras que el peso, IMC y nivel de glucosa fueron significativamente menores que en Mala. No hubo diferencia significativa entre los niveles séricos de sCD36 de ambas poblaciones. Se observó una diferencia significativa entre los valores medios de sCD36 según el IMC, y una correlación positiva significativa entre sCD36 y el peso e IMC. Conclusiones: El nivel sérico observado de sCD36 es independiente de la altitud y puede ser considerado como marcador potencial de síndrome metabólico

Objectives: To determine the serum levels of sCD36, a lipid metabolism-related molecule, in high-altitude and sea-level populations, and to establish the association of this parameter with cardiometabolic risk factors. Materials and methods: The study population consisted of 45 people from Carhuamayo (4100 masl) and 40 people from Mala (30 masl). Weight, height and blood pressure were measured. Hemoglobin was determined in whole blood, and glucose, lipid profile and sCD36 in serum. Results: It has been found that hemoglobin levels in the population of Carhuamayo were significantly higher, while weight, BMI and glucose level were significantly lower than those in the population of Mala. There was no significant difference between serum levels of sCD36 in both populations. A significant difference was observed between sCD36 mean serum levels of both populations based on the BMI, and a significant positive correlation between sCD36 and the weight and BMI. Conclusions: The observed sCD36 serum level is not related to the altitude and can be considered as a potential marker of metabolic syndrome

Assuntos